The inhibition of hepatic steatosis is associated with many mechanisms, including reduced fat production, increased fatty acid β-oxidation, increased insulin sensitivity, the inhibition of oxidative stress, and the inhibition of activation of the inflammatory pathway (64). Here, INS is linked to fatty liver disease.